SUVRETTA CAPITAL MANAGEMENT, LLC - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2024$270,000
-97.8%
75,000
-97.9%
0.01%
-97.8%
Q1 2024$12,056,530
-29.2%
3,653,494
-50.4%
0.45%
-41.8%
Q4 2023$17,026,636
+79.2%
7,370,838
+0.1%
0.77%
+50.1%
Q3 2023$9,500,125
-2.3%
7,364,4380.0%0.51%
-1.3%
Q2 2023$9,721,058
+86.7%
7,364,4380.0%0.52%
+136.4%
Q1 2023$5,205,921
-5.7%
7,364,4380.0%0.22%
-5.2%
Q4 2022$5,523,329
-12.9%
7,364,4380.0%0.23%
-11.8%
Q3 2022$6,342,000
-38.1%
7,364,438
-19.4%
0.26%
-32.4%
Q2 2022$10,239,0000.0%9,142,0670.0%0.39%
+24.3%
Q1 2022$10,239,000
-30.0%
9,142,0670.0%0.31%
+10.6%
Q4 2021$14,627,000
-33.9%
9,142,0670.0%0.28%
-24.1%
Q3 2021$22,124,000
-19.3%
9,142,067
+5.7%
0.37%
-9.0%
Q2 2021$27,418,000
+27.8%
8,649,300
+35.9%
0.41%
+29.3%
Q1 2021$21,452,000
+118.0%
6,365,500
+131.6%
0.32%
+124.8%
Q4 2020$9,841,0002,748,9990.14%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Tejara Capital Ltd 2,435,806$1,721,8710.88%
Monaco Asset Management SAM 1,316,245$930,4540.28%
DAFNA Capital Management LLC 1,096,513$775,1250.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,364,438$5,205,9210.22%
Clearline Capital LP 2,052,709$1,451,0600.22%
Rubric Capital Management LP 10,366,120$7,327,8100.19%
Orbimed Advisors 7,747,891$5,476,9840.11%
Rock Springs Capital Management LP 6,244,897$4,414,5180.10%
683 Capital Management, LLC 2,000,000$1,413,8010.10%
Privium Fund Management (UK) Ltd 177,200$131,1280.10%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders